Recurrence rates after strictureplasty for small bowel Crohn's disease remain high in the era of biologics
Strictureplasty remains a safe and effective surgical treatment for small bowel CD. Recurrence and reoperation rates remain high, regardless of postoperative biologic therapy. Smoking significantly increases the risk of recurrence.
Authors
- Justin Davies (ORCID: https://orcid.org/0000-0001-6904-1255)
- Antonio Luberto (ORCID: https://orcid.org/0000-0002-1202-9447)
- Antonino Spinelli (ORCID: https://orcid.org/0000-0002-1493-1768)
- Akash Mehta (ORCID: https://orcid.org/0000-0002-4973-3016)
- Janindra Warusavitarne (ORCID: https://orcid.org/0000-0002-7950-2833)
- Michele Carvello (ORCID: https://orcid.org/0000-0002-8650-2321)
- T. Morrison
- Aref El Nasasra
- Keith J. Williams
Institutions
- Humanitas University (IT)
- University of Cambridge (GB)
- London North West Healthcare NHS Trust (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Frimley Health NHS Foundation Trust (GB)
- Addenbrooke's Hospital (GB)
- St Mark's Hospital (GB)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Colorectal Disease
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1111/codi.17224
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.10